Literature DB >> 24753038

Assessing the goodness of fit of personal risk models.

Gail Gong1, Anne S Quante, Mary Beth Terry, Alice S Whittemore.   

Abstract

We describe a flexible family of tests for evaluating the goodness of fit (calibration) of a pre-specified personal risk model to the outcomes observed in a longitudinal cohort. Such evaluation involves using the risk model to assign each subject an absolute risk of developing the outcome within a given time from cohort entry and comparing subjects' assigned risks with their observed outcomes. This comparison involves several issues. For example, subjects followed only for part of the risk period have unknown outcomes. Moreover, existing tests do not reveal the reasons for poor model fit when it occurs, which can reflect misspecification of the model's hazards for the competing risks of outcome development and death. To address these issues, we extend the model-specified hazards for outcome and death, and use score statistics to test the null hypothesis that the extensions are unnecessary. Simulated cohort data applied to risk models whose outcome and mortality hazards agreed and disagreed with those generating the data show that the tests are sensitive to poor model fit, provide insight into the reasons for poor fit, and accommodate a wide range of model misspecification. We illustrate the methods by examining the calibration of two breast cancer risk models as applied to a cohort of participants in the Breast Cancer Family Registry. The methods can be implemented using the Risk Model Assessment Program, an R package freely available at http://stanford.edu/~ggong/rmap/.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  absolute risk; cohort data; efficient score statistics; goodness of fit; personal disease risk; standardized residuals

Mesh:

Year:  2014        PMID: 24753038      PMCID: PMC4362710          DOI: 10.1002/sim.6176

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  7 in total

1.  Validation studies for models projecting the risk of invasive and total breast cancer incidence.

Authors:  J P Costantino; M H Gail; D Pee; S Anderson; C K Redmond; J Benichou; H S Wieand
Journal:  J Natl Cancer Inst       Date:  1999-09-15       Impact factor: 13.506

2.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

Authors:  M H Gail; L A Brinton; D P Byar; D K Corle; S B Green; C Schairer; J J Mulvihill
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

3.  Two-stage sampling designs for external validation of personal risk models.

Authors:  Alice S Whittemore; Jerry Halpern
Journal:  Stat Methods Med Res       Date:  2013-04-16       Impact factor: 3.021

4.  A breast cancer prediction model incorporating familial and personal risk factors.

Authors:  Jonathan Tyrer; Stephen W Duffy; Jack Cuzick
Journal:  Stat Med       Date:  2004-04-15       Impact factor: 2.373

5.  Projecting individualized absolute invasive breast cancer risk in African American women.

Authors:  Mitchell H Gail; Joseph P Costantino; David Pee; Melissa Bondy; Lisa Newman; Mano Selvan; Garnet L Anderson; Kathleen E Malone; Polly A Marchbanks; Worta McCaskill-Stevens; Sandra A Norman; Michael S Simon; Robert Spirtas; Giske Ursin; Leslie Bernstein
Journal:  J Natl Cancer Inst       Date:  2007-11-27       Impact factor: 13.506

6.  The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer.

Authors:  Esther M John; John L Hopper; Jeanne C Beck; Julia A Knight; Susan L Neuhausen; Ruby T Senie; Argyrios Ziogas; Irene L Andrulis; Hoda Anton-Culver; Norman Boyd; Saundra S Buys; Mary B Daly; Frances P O'Malley; Regina M Santella; Melissa C Southey; Vickie L Venne; Deon J Venter; Dee W West; Alice S Whittemore; Daniela Seminara
Journal:  Breast Cancer Res       Date:  2004-05-19       Impact factor: 6.466

7.  Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.

Authors:  Anne S Quante; Alice S Whittemore; Tom Shriver; Konstantin Strauch; Mary B Terry
Journal:  Breast Cancer Res       Date:  2012-11-05       Impact factor: 6.466

  7 in total
  7 in total

1.  Deep learning for cardiovascular medicine: a practical primer.

Authors:  Chayakrit Krittanawong; Kipp W Johnson; Robert S Rosenson; Zhen Wang; Mehmet Aydar; Usman Baber; James K Min; W H Wilson Tang; Jonathan L Halperin; Sanjiv M Narayan
Journal:  Eur Heart J       Date:  2019-07-01       Impact factor: 29.983

2.  Evaluating disease prediction models using a cohort whose covariate distribution differs from that of the target population.

Authors:  Scott Powers; Valerie McGuire; Leslie Bernstein; Alison J Canchola; Alice S Whittemore
Journal:  Stat Methods Med Res       Date:  2017-08-16       Impact factor: 3.021

3.  Predicting Prostate Cancer Recurrence After Radical Prostatectomy.

Authors:  Abra Jeffers; Vanessa Sochat; Michael W Kattan; Changhong Yu; Erin Melcon; Kosj Yamoah; Timothy R Rebbeck; Alice S Whittemore
Journal:  Prostate       Date:  2016-10-24       Impact factor: 4.104

4.  Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort.

Authors:  Robert J MacInnis; Julia A Knight; Wendy K Chung; Roger L Milne; Alice S Whittemore; Richard Buchsbaum; Yuyan Liao; Nur Zeinomar; Gillian S Dite; Melissa C Southey; David Goldgar; Graham G Giles; Allison W Kurian; Irene L Andrulis; Esther M John; Mary B Daly; Saundra S Buys; Kelly-Anne Phillips; John L Hopper; Mary Beth Terry
Journal:  J Natl Cancer Inst       Date:  2021-06-01       Impact factor: 13.506

5.  iCARE: An R package to build, validate and apply absolute risk models.

Authors:  Parichoy Pal Choudhury; Paige Maas; Amber Wilcox; William Wheeler; Mark Brook; David Check; Montserrat Garcia-Closas; Nilanjan Chatterjee
Journal:  PLoS One       Date:  2020-02-05       Impact factor: 3.240

6.  Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk.

Authors:  Anne S Quante; Alice S Whittemore; Tom Shriver; John L Hopper; Konstantin Strauch; Mary Beth Terry
Journal:  J Natl Cancer Inst       Date:  2015-05-08       Impact factor: 13.506

7.  Circulating growth factor concentrations and breast cancer risk: a nested case-control study of IGF-1, IGFBP-3, and breast cancer in a family-based cohort.

Authors:  Kelsey R Monson; Mandy Goldberg; Hui-Chen Wu; Regina M Santella; Wendy K Chung; Mary Beth Terry
Journal:  Breast Cancer Res       Date:  2020-10-22       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.